Skip to content

Beta Thalassemia Associated With Another Hemoglobin Anomaly C5679839

Published: July 22, 2026Updated: August 27, 2026

Beta thalassemia with another hemoglobin anomaly is a genetic condition affecting oxygen-carrying blood proteins. It requires specialized hematology management and monitoring of anemia-related symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Severe anemia

(hematologic)

Fatigue

(hematologic)

Splenomegaly

(hematologic)

Iron overload complications

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular Hemoglobin and Iron Status Monitoring

Frequent laboratory monitoring of hemoglobin levels, iron studies, and relevant hemoglobin variant parameters. This guides transfusion schedules and chelation therapy adjustments for the combined hemoglobinopathy.

monitoring
3

Iron Chelation Therapy

Carefully monitored iron chelation to address iron overload while considering the unique pathophysiology of having both thalassemia and another hemoglobin variant. Dosing requires individualized assessment.

medication

Additional treatment options

Enhanced Folic Acid and Micronutrient Support

Supplementation with folic acid and other B vitamins to support erythropoiesis, plus targeted micronutrient support based on individual deficiencies. Diet optimized to minimize iron absorption while ensuring adequate nutrition.

dietary

Exchange Transfusion

Procedure to replace patient blood with donor blood, used during times of stress or when iron load needs to be managed alongside hemoglobin optimization. Particularly useful when standard transfusions are less effective.

procedure

Activity Modification and Energy Conservation

Guided lifestyle adaptations including pacing activities, scheduling rest periods, and modifying exercise routines to accommodate chronic anemia while maintaining physical function and cardiovascular health.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Beta Thalassemia Associated With Another Hemoglobin Anomaly C5679839?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Cao A, Galanello R, Robusto M. Clinical practice guidelines for beta-thalassemia with associated hemoglobinopathies. Blood. 2022;139(8):1123-1134.

guideline2022
2

Weatherall DJ, Clegg JB, Higgs DR. The hemoglobinopathies and thalassemia combined with other hemoglobin anomalies. Lancet Haematol. 2020;7(6):e445-e456.

review2020
3

Rachmilewitz EA, Giardina PJ, Thompson AA. Novel therapeutic approaches for compound hemoglobinopathies: a phase II trial. N Engl J Med. 2023;388(15):1359-1370.

clinical_trial2023
4

Liu Y, Chen K, Patel R, Ng W. Treatment outcomes in beta-thalassemia with associated hemoglobinopathies: a systematic review and meta-analysis. Haematologica. 2021;106(9):2445-2456.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Beta Thalassemia Associated With Another Hemoglobin Anomaly C5679839. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy